GDF9 and polycystic ovary syndrome: In addition, research on ovary tissues from women with polycystic ovary syndrome (PCOS) revealed that GDF9 mRNA expression is substantially delayed and reduced during the growth and differentiation phase [55] and cannot reach the normal level even after ovarian stimulation, which is the premise for impaired oocyte quality and developmental competence in PCOS females [56].